Transcatheter aortic valve replacement and vascular complications definitions
EuroIntervention 9(11): 1317-1322
Article 2014 English
Authors
NM
Nicolas M. Van Mieghem
PG
Philippe Généreux
RB
Robert M.A. van der Boon
Abstract
1 min read
Transcatheter aortic valve replacement (TAVR) requires large calibre catheters and is therefore associated with increased vascular complications. The aim of this study was to illustrate the impact of the different definitions of major vascular complications on their incidence and to underscore the importance of uniform reporting.We pooled dedicated databases of consecutive patients undergoing TAVR from two tertiary care facilities and looked for the incidence of major vascular complications using various previously reported definitions. The level of agreement (Kappa statistic) between the respective definitions and the Valve Academic Research Consortium (VARC) consensus definition of vascular complications was assessed. A total of 345 consecutive patients underwent transfemoral TAVR and were included in this analysis. A completely percutaneous access and closure technique was applied in 96% of cases. Arterial sheath size ranged between 18 and 24 Fr, the majority being 18 Fr (60%). Procedural success was reached in 94.5%. Depending on the definition used, major vascular complications occurred in 5.2-15.9% of patients. According to the VARC definitions, the rate of major and minor vascular complications was 9.0% and 9.6%, respectively. Major vascular complications according to VARC criteria demonstrated at least a substantial level of agreement with the SOURCE registry (k 0.80), the UK registry (k 0.82) the Italian registry (k 0.72) and "FRANCE" registry (k 0.70) definitions, compared to a moderate level of agreement with the definitions used in the German registry ( 0.47) and the 18 Fr Safety and Efficacy study (k 0.42). Minor complications according to VARC demonstrated a moderate agreement only with vascular complications using the German registry definition (k 0.54).Non-uniformity in how vascular complications are defined precludes any reliable comparison between previously reported TAVR registries. The VARC consensus document offers standardised endpoint definitions and should be universally adopted to obtain better insights into global TAVR experience.
Philippe Généreux, Stuart J. Head, Nicolas M. Van Mieghem, Susheel Kodali, Ajay J. Kirtane, Ke Xu, Craig R. Smith, Patrick W. Serruys, A. Pieter Kappetein, Martin B. Leon
Rutger‐Jan Nuis, Nicolò Piazza, Nicolas M. Van Mieghem, A. Otten, Apostolos Tzikas, Carl Schultz, Robert van der Boon, Robert‐Jan van Geuns, Ron T. van Domburg, Peter J. Koudstaal, A. Pieter Kappetein, Patrick W. Serruys, Peter P. de Jaegere
A. Pieter Kappetein, Stuart J. Head, Philippe Généreux, Nicolò Piazza, Nicolas M. Van Mieghem, Eugene H. Blackstone, Thomas Brott, David J. Cohen, Donald E. Cutlip, Gerrit‐Anne van Es, Rebecca T. Hahn, Ajay J. Kirtane, Mitchell W. Krucoff, Susheel Kodali, Michael J. Mack, Roxana Mehran, Josep Rodés‐Cabau, Pascal Vranckx, John G. Webb, Stephan Windecker, Patrick W. Serruys, Martin B. Leon
A. Pieter Kappetein, Stuart J. Head, Philippe Généreux, Nicolò Piazza, Nicolas M. Van Mieghem, Eugene H. Blackstone, Thomas Brott, David J. Cohen, Donald E. Cutlip, Gerrit‐Anne van Es, Rebecca T. Hahn, Ajay J. Kirtane, Mitchell W. Krucoff, Susheel Kodali, Michael J. Mack, Roxana Mehran, Josep Rodés‐Cabau, Pascal Vranckx, John G. Webb, Stephan Windecker, Patrick W. Serruys, Martin B. Leon
Discussion(0)
No comments yet. Be the first to comment.